119 related articles for article (PubMed ID: 17762173)
1. Altered biogenesis of deltaF508-CFTR following treatment with doxorubicin.
Maitra R; Hamilton JW
Cell Physiol Biochem; 2007; 20(5):465-72. PubMed ID: 17762173
[TBL] [Abstract][Full Text] [Related]
2. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
[TBL] [Abstract][Full Text] [Related]
3. The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment.
Yang Y; Janich S; Cohn JA; Wilson JM
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9480-4. PubMed ID: 7692448
[TBL] [Abstract][Full Text] [Related]
4. Organic solutes rescue the functional defect in delta F508 cystic fibrosis transmembrane conductance regulator.
Zhang XM; Wang XT; Yue H; Leung SW; Thibodeau PH; Thomas PJ; Guggino SE
J Biol Chem; 2003 Dec; 278(51):51232-42. PubMed ID: 14532265
[TBL] [Abstract][Full Text] [Related]
5. Increased functional cell surface expression of CFTR and DeltaF508-CFTR by the anthracycline doxorubicin.
Maitra R; Shaw CM; Stanton BA; Hamilton JW
Am J Physiol Cell Physiol; 2001 May; 280(5):C1031-7. PubMed ID: 11287314
[TBL] [Abstract][Full Text] [Related]
6. ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.
Pankow S; Bamberger C; Calzolari D; Martínez-Bartolomé S; Lavallée-Adam M; Balch WE; Yates JR
Nature; 2015 Dec; 528(7583):510-6. PubMed ID: 26618866
[TBL] [Abstract][Full Text] [Related]
7. Functional activation of the cystic fibrosis trafficking mutant delta F508-CFTR by overexpression.
Cheng SH; Fang SL; Zabner J; Marshall J; Piraino S; Schiavi SC; Jefferson DM; Welsh MJ; Smith AE
Am J Physiol; 1995 Apr; 268(4 Pt 1):L615-24. PubMed ID: 7733303
[TBL] [Abstract][Full Text] [Related]
8. Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating.
Yang H; Shelat AA; Guy RK; Gopinath VS; Ma T; Du K; Lukacs GL; Taddei A; Folli C; Pedemonte N; Galietta LJ; Verkman AS
J Biol Chem; 2003 Sep; 278(37):35079-85. PubMed ID: 12832418
[TBL] [Abstract][Full Text] [Related]
9. Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR.
Zhang F; Kartner N; Lukacs GL
Nat Struct Biol; 1998 Mar; 5(3):180-3. PubMed ID: 9501909
[TBL] [Abstract][Full Text] [Related]
10. Mammalian osmolytes and S-nitrosoglutathione promote Delta F508 cystic fibrosis transmembrane conductance regulator (CFTR) protein maturation and function.
Howard M; Fischer H; Roux J; Santos BC; Gullans SR; Yancey PH; Welch WJ
J Biol Chem; 2003 Sep; 278(37):35159-67. PubMed ID: 12837761
[TBL] [Abstract][Full Text] [Related]
11. Calnexin Delta 185-520 partially reverses the misprocessing of the Delta F508 cystic fibrosis transmembrane conductance regulator.
Okiyoneda T; Wada I; Jono H; Shuto T; Yoshitake K; Nakano N; Nagayama S; Harada K; Isohama Y; Miyata T; Kai H
FEBS Lett; 2002 Aug; 526(1-3):87-92. PubMed ID: 12208510
[TBL] [Abstract][Full Text] [Related]
12. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.
Dalemans W; Barbry P; Champigny G; Jallat S; Dott K; Dreyer D; Crystal RG; Pavirani A; Lecocq JP; Lazdunski M
Nature; 1991 Dec 19-26; 354(6354):526-8. PubMed ID: 1722027
[TBL] [Abstract][Full Text] [Related]
13. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR.
Rubenstein RC; Egan ME; Zeitlin PL
J Clin Invest; 1997 Nov; 100(10):2457-65. PubMed ID: 9366560
[TBL] [Abstract][Full Text] [Related]
14. The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR.
Li C; Ramjeesingh M; Reyes E; Jensen T; Chang X; Rommens JM; Bear CE
Nat Genet; 1993 Apr; 3(4):311-6. PubMed ID: 7526932
[TBL] [Abstract][Full Text] [Related]
15. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
French PJ; van Doorninck JH; Peters RH; Verbeek E; Ameen NA; Marino CR; de Jonge HR; Bijman J; Scholte BJ
J Clin Invest; 1996 Sep; 98(6):1304-12. PubMed ID: 8823295
[TBL] [Abstract][Full Text] [Related]
16. Dysfunction of CFTR bearing the delta F508 mutation.
Welsh MJ; Denning GM; Ostedgaard LS; Anderson MP
J Cell Sci Suppl; 1993; 17():235-9. PubMed ID: 7511616
[TBL] [Abstract][Full Text] [Related]
17. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.
Brown CR; Hong-Brown LQ; Biwersi J; Verkman AS; Welch WJ
Cell Stress Chaperones; 1996 Jun; 1(2):117-25. PubMed ID: 9222597
[TBL] [Abstract][Full Text] [Related]
18. Functional stability of rescued delta F508 cystic fibrosis transmembrane conductance regulator in airway epithelial cells.
Jurkuvenaite A; Chen L; Bartoszewski R; Goldstein R; Bebok Z; Matalon S; Collawn JF
Am J Respir Cell Mol Biol; 2010 Mar; 42(3):363-72. PubMed ID: 19502384
[TBL] [Abstract][Full Text] [Related]
19. Mutation of R555 in CFTR-delta F508 enhances function and partially corrects defective processing.
Teem JL; Carson MR; Welsh MJ
Recept Channels; 1996; 4(1):63-72. PubMed ID: 8723647
[TBL] [Abstract][Full Text] [Related]
20. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.
Denning GM; Anderson MP; Amara JF; Marshall J; Smith AE; Welsh MJ
Nature; 1992 Aug; 358(6389):761-4. PubMed ID: 1380673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]